These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8363183)

  • 1. Alopecia associated with fluconazole treatment.
    Weinroth SE; Tuazon CU
    Ann Intern Med; 1993 Oct; 119(7 Pt 1):637. PubMed ID: 8363183
    [No Abstract]   [Full Text] [Related]  

  • 2. Alopecia associated with fluconazole therapy.
    Pappas PG; Kauffman CA; Perfect J; Johnson PC; McKinsey DS; Bamberger DM; Hamill R; Sharkey PK; Chapman SW; Sobel JD
    Ann Intern Med; 1995 Sep; 123(5):354-7. PubMed ID: 7625624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alopecia associated with fluconazole therapy.
    Goldsmith LA
    Ann Intern Med; 1996 Jul; 125(2):153; author reply 153-4. PubMed ID: 8678374
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction between fluconazole and rifampicin.
    Coker RJ; Tomlinson DR; Parkin J; Harris JR; Pinching AJ
    BMJ; 1990 Oct; 301(6755):818. PubMed ID: 2224282
    [No Abstract]   [Full Text] [Related]  

  • 5. Graded challenge protocol for fluconazole hypersensitivity in a patient with cryptococcal pneumonitis.
    Rankin BT; Jariwala S
    Ann Allergy Asthma Immunol; 2012 Jun; 108(6):466. PubMed ID: 22626606
    [No Abstract]   [Full Text] [Related]  

  • 6. Desenitization to fluconazole in an AIDS patient.
    Takahashi T; Hitani A; Yamada H; Nakamura T; Iwamoto A
    Ann Pharmacother; 2001 May; 35(5):642-3. PubMed ID: 11346073
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluconazole-induced thrombocytopenia.
    Agarwal A; Sakhuja V; Chugh KS
    Ann Intern Med; 1990 Dec; 113(11):899. PubMed ID: 2240909
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluconazole.
    Med Lett Drugs Ther; 1990 May; 32(818):50-2. PubMed ID: 2185400
    [No Abstract]   [Full Text] [Related]  

  • 9. Survival following fulminant hepatic failure from fluconazole induced hepatitis.
    Crerar-Gilbert A; Boots R; Fraenkel D; MacDonald GA
    Anaesth Intensive Care; 1999 Dec; 27(6):650-2. PubMed ID: 10631423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety evaluation of chronic fluconazole therapy. Fluconazole Pan-American Study Group.
    Stevens DA; Diaz M; Negroni R; Montero-Gei F; Castro LG; Sampaio SA; Borelli D; Restrepo A; Franco L; Bran JL; Arathoon EG
    Chemotherapy; 1997; 43(5):371-7. PubMed ID: 9309372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fluconazole--a new antifungal agent].
    Dobloug JH
    Tidsskr Nor Laegeforen; 1992 Jun; 112(15):1961-3. PubMed ID: 1509458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel method of desensitization for fluconazole hypersensitivity in a patient with AIDS.
    Jariwala S; Vernon N; de Vos G
    Ann Allergy Asthma Immunol; 2011 Jun; 106(6):542-3. PubMed ID: 21624759
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluconazole and itraconazole: current status and prospects for antifungal therapy.
    Sugar AM
    Curr Clin Top Infect Dis; 1993; 13():74-98. PubMed ID: 8397919
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical description of three cases of cerebral cryptococcosis in patients with AIDS treated with fluconazole].
    Izzo E; Piccinino R; Caruso I; Bisogno A; Pesce G; Liberti A
    Riv Eur Sci Med Farmacol; 1991; 13(3-4):173-7. PubMed ID: 1821053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    Saag MS; Cloud GA; Graybill JR; Sobel JD; Tuazon CU; Johnson PC; Fessel WJ; Moskovitz BL; Wiesinger B; Cosmatos D; Riser L; Thomas C; Hafner R; Dismukes WE
    Clin Infect Dis; 1999 Feb; 28(2):291-6. PubMed ID: 10064246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulmonary cryptococcosis treated by combination therapy of fluconazole plus flucytosine].
    Tanaka K; Kohno S; Maesaki S; Mitsutake K; Miyazaki H; Miyazaki T; Tomono K; Kaku M; Koga H; Hara K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31(12):1528-33. PubMed ID: 8121088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of asymptomatic pulmonary cryptococcosis in immunocompetent hosts with oral fluconazole.
    Choi KH; Park SJ; Min KH; Kim SR; Lee MH; Chung CR; Han HJ; Lee YC
    Scand J Infect Dis; 2011 May; 43(5):380-5. PubMed ID: 21271944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group.
    Bozzette SA; Larsen RA; Chiu J; Leal MA; Jacobsen J; Rothman P; Robinson P; Gilbert G; McCutchan JA; Tilles J
    N Engl J Med; 1991 Feb; 324(9):580-4. PubMed ID: 1992319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial therapy for acquired immunodeficiency syndrome-associated cryptococcosis with fluconazole.
    Nightingale SD
    Arch Intern Med; 1995 Mar; 155(5):538-40. PubMed ID: 7864710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous effects associated with fluconazole in patients treated for coccidioidomycosis.
    Brewer AC; Huber JT; Girardo ME; Kosiorek HE; Burns MW; Stewart TD; Blair JE
    Int J Dermatol; 2019 Feb; 58(2):250-253. PubMed ID: 30229876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.